PSIL AdvisorShares Psychedelics ETF
This actively managed Exchange Traded Fund (ETF) endeavors to meet its investment goals by typically allocating a minimum of 80% of its total net assets (including any capital secured through borrowing for investment purposes) into the securities of specific companies. To be eligible for inclusion, these companies must either derive at least half of their net revenue from, or commit 50% or more of their assets to, psychedelic compounds, their derivatives, or other financial instruments exhibiting similar economic characteristics. The fund's primary holdings consist of publicly traded life sciences firms focused on psychedelic medical treatments, in addition to other businesses involved in the broader psychedelics sector. It is important to note that this fund maintains a concentrated, non-diversified portfolio.
Performance
| 1M | 3M | YTD | 1Y | 3Y ann. | 5Y ann. | |
|---|---|---|---|---|---|---|
| PSIL | -5.9% | -24.3% | +11.3% | +7.4% | +13.4% | -26.4% |
| Equity average (4725 funds) | -2.2% | +2.5% | +85.7% | +59908.1% | +13.6% | +2.3% |
Insider activity in the holdings
Open-market insider buying across this fund’s holdings over 90 days, weighted by holding weight: +$114K net.
Holdings · as of Nov 13, 2026
| # | Holding | Weight |
|---|---|---|
| 1 | DFTX DEFINIUM THERAPEUTICS INC | 11.84% |
| 2 | CMPS COMPASS PATHWAYS PLC | 10.56% |
| 3 | HELP HELUS PHARMA INC | 7.89% |
| 4 | LLY ELI LILLY & CO | 6.55% |
| 5 | RLMD RELMADA THERAPEUTICS INC | 6.27% |
| 6 | NBIX NEUROCRINE BIOSCIENCES INC | 5.94% |
| 7 | ABBV ABBVIE INC | 5.84% |
| 8 | SPTX SEAPORT THERAPEUTICS INC | 5.16% |
| 9 | ANRO ALTO NEUROSCIENCE INC | 5.15% |
| 10 | INDV SUPERNUS INC | 4.88% |
| 11 | JNJ JOHNSON & JOHNSON | 4.81% |
| 12 | GHRS GH RESEARCH PLC | 4.42% |
| 13 | NRXP NRX PHARMACEUTICALS INC | 3.96% |
| 14 | STIM NEURONETICS INC | 3.51% |
| 15 | DRUG BRIGHT MINDS BIOSCIENCES INC | 2.57% |
| 16 | PSIL BLACKROCK TREASURY TRUST INSTL 62 | 2.15% |
| 17 | PBM PSYENCE BIOMEDICAL LTD | 1.87% |
| 18 | NEUP NEUPHORIA THERAPEUTICS INC | 1.75% |
| 19 | QNTM QUANTUM BIOPHARMA-B SUB VOT | 1.63% |
| 20 | OPTH OPTIMI HEALTH CORP | 1.39% |
| 21 | IXHL INCANNEX HEALTHCARE INC | 0.74% |
| 22 | SILO SILO PHARMA INC | 0.43% |
| 23 | IGC IGC PHARMA INC | 0.38% |
| 24 | NUMIF NUMINUS WELLNESS INC | 0.30% |
Sector breakdown
Country breakdown
Distributions
| Date | Per unit |
|---|---|
| Dec 22, 2025 | $1.6839 |
| Sep 22, 2025 | $0.0201 |
| Jun 23, 2025 | $0.0119 |
| Mar 21, 2025 | $0.1634 |
| Dec 23, 2024 | $0.0548 |
| Sep 23, 2024 | $0.1087 |
| Sep 25, 2023 | $0.0336 |
| Sep 26, 2022 | $0.5421 |
Members of Congress who disclosed this ETF
No member of Congress has disclosed a trade in PSIL in the filings we hold.
Fund facts, prices, performance and distributions: our market-data vendor. Holdings: the vendor and SEC Form N-PORT. Insider and Congress data: InsiderBuying. Last updated Nov 13, 2026. This is historical data, not investment advice. Report a data error